November 24, 2015
Gilead Sciences to Present at Two Upcoming Investor Conferences on Tuesday, December 1
- 33rd NASDAQ OMX Investor
- Piper Jaffray 27th Annual
Healthcare Conference -
- Webcasts Available Through Gilead Corporate Website -
FOSTER CITY, Calif.--(BUSINESS WIRE)--Nov. 24, 2015--
Gilead Sciences, Inc. (Nasdaq: GILD) today announced webcasts from two
upcoming investor conferences: the 33rd NASDAQ OMX Investor
Program in London and the Piper Jaffray 27th Annual
Healthcare Conference in New York.
Robin L. Washington, Gilead’s Executive Vice President and Chief
Financial Officer, will participate in a fireside chat at the NASDAQ
conference on Tuesday, December 1 at 10:15 a.m. Greenwich Mean Time
(5:15 a.m. Eastern Time).
Paul R. Carter, Gilead’s Executive Vice President, Commercial
Operations, will participate in a fireside chat at the Piper Jaffray
conference on Tuesday, December 1 at 9:30 a.m. Eastern Time.
The live webcast can be accessed at the company’s Investors page at www.gilead.com/investors.
Please connect to the company’s website at least 15 minutes prior to the
start of the presentation to ensure adequate time for any software
download that may be required to listen to the webcast. The replay will
be available for 14 days following the presentation.
Gilead Sciences is a biopharmaceutical company that discovers, develops
and commercializes innovative therapeutics in areas of unmet medical
need. The company’s mission is to advance the care of patients suffering
from life-threatening diseases. Gilead has operations in more than 30
countries worldwide, with headquarters in Foster City, California.
For more information on Gilead Sciences, please visit the company’s
website at www.gilead.com,
follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs
at 1-800-GILEAD-5 or 1-650-574-3000.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151124005944/en/
Source: Gilead Sciences, Inc.
Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936